BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33032813)

  • 21. T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease.
    Schneider GK; Stroeder J; Roditi G; Colosimo C; Armstrong P; Martucci M; Buecker A; Raczeck P
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1799-1806. PubMed ID: 28642266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
    Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium Deposition within the Pediatric Brain: No Increased Intrinsic T1-Weighted Signal Intensity within the Dentate Nucleus following the Administration of a Minimum of 4 Doses of the Macrocyclic Agent Gadoteridol.
    Young JR; Pope WB; Bobinski M
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1604-1608. PubMed ID: 30093477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
    Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
    Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
    Roberts DR; Chatterjee AR; Yazdani M; Marebwa B; Brown T; Collins H; Bolles G; Jenrette JM; Nietert PJ; Zhu X
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2340-2347. PubMed ID: 27469211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
    Krug KB; Burke CJ; Weiss K; Baltzer PAT; Rhiem K; Maintz D; Schlamann M; Hellmich M
    Eur Radiol; 2022 Jan; 32(1):331-345. PubMed ID: 34218287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
    Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
    Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.
    Towbin AJ; Zhang B; Dillman JR
    Pediatr Radiol; 2021 Dec; 51(13):2568-2580. PubMed ID: 34286351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
    Splendiani A; Corridore A; Torlone S; Martino M; Barile A; Di Cesare E; Masciocchi C
    Insights Imaging; 2019 Sep; 10(1):82. PubMed ID: 31482392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
    Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
    Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
    Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
    Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
    Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
    Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
    Cao Y; Huang DQ; Shih G; Prince MR
    AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
    Barisano G; Bigjahan B; Metting S; Cen S; Amezcua L; Lerner A; Toga AW; Law M
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1274-1281. PubMed ID: 31345942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
    Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
    Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.
    Zhang Y; Cao Y; Shih GL; Hecht EM; Prince MR
    Radiology; 2017 Feb; 282(2):516-525. PubMed ID: 27513848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between high signal intensity in cerebrum nucleus on unenhanced T
    Pei L; Xu J; Zhang M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):487-491. PubMed ID: 29488714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
    Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
    Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.